Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  London Stock Exchange  >  AstraZeneca PLC    AZN   GB0009895292

ASTRAZENECA PLC

(AZN)
  Report
Real-time Estimate Quote. Real-time Estimate CHI-X - 08/14 11:30:00 am
8381 GBX   -1.88%
05:16pNEWS HIGHLIGHTS : Top Company News of the Day
DJ
05:02pMcKesson Tapped to Distribute Coronavirus Vaccines in U.S.
DJ
03:16pNEWS HIGHLIGHTS : Top Company News of the Day
DJ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsAnalyst Recommendations

ASTRAZENECA : Goldman Sachs reiterates its Sell rating

share with twitter share with LinkedIn share with facebook
07/16/2020 | 07:41am EDT

Goldman Sachs analyst Keyur Parekh maintains his Sell rating on ASTRAZENECA. The target price continues to be set at GBX 6000.

Stocks mentioned in the article
ChangeLast1st jan.
ASTRAZENECA PLC -1.88% 8381 Delayed Quote.12.29%
THE GOLDMAN SACHS GROUP, INC. -0.20% 207.97 Delayed Quote.-7.74%

© MarketScreener with dpa-AFX Analyser 2020
share with twitter share with LinkedIn share with facebook
Toute l'actualité sur ASTRAZENECA PLC
05:16pNEWS HIGHLIGHTS : Top Company News of the Day
DJ
05:02pMcKesson Tapped to Distribute Coronavirus Vaccines in U.S.
DJ
03:16pNEWS HIGHLIGHTS : Top Company News of the Day
DJ
02:09pTrump Administration picks McKesson for coronavirus vaccine distribution
RE
01:16pNEWS HIGHLIGHTS : Top Company News of the Day
DJ
12:50pASTRAZENECA : concludes agreement with the European Commission for the supply of..
AQ
12:10pTrump Administration picks McKesson for coronavirus vaccine distribution
RE
12:00pVaccine makers including Moderna must hit U.S. timing goals for full payments
RE
11:36aEU Secures Coronavirus Vaccine Deal With AstraZeneca
DJ
10:14aVaccine makers including Moderna must hit U.S. timing goals for full payments
RE
More news
Financials (USD)
Sales 2020 26 712 M - -
Net income 2020 3 067 M - -
Net Debt 2020 13 578 M - -
P/E ratio 2020 38,4x
Yield 2020 3,35%
Capitalization 110 B 144 B -
EV / Sales 2020 4,63x
EV / Sales 2021 4,05x
Nbr of Employees 70 600
Free-Float 95,7%
Chart ASTRAZENECA PLC
Duration : Period :
AstraZeneca PLC Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ASTRAZENECA PLC
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 24
Average target price 113,90 $
Last Close Price 83,81 $
Spread / Highest target 73,7%
Spread / Average Target 35,9%
Spread / Lowest Target -28,4%
EPS Revisions
Managers
NameTitle
Pascal Soriot Chief Executive Officer & Executive Director
Leif Valdemar Johansson Non-Executive Chairman
Pam P. Cheng Executive VP-Operations & Information Technology
Marc Pierre Jean Dunoyer Chief Financial Officer & Executive Director
Menelas N. Pangalos EVP-Biopharmaceuticals Research & Development
Sector and Competitors
1st jan.Capitalization (M$)
ASTRAZENECA PLC12.29%146 662
JOHNSON & JOHNSON2.60%389 658
ROCHE HOLDING AG0.45%296 698
PFIZER, INC.-2.58%212 106
MERCK & CO., INC.-8.15%211 293
NOVARTIS AG-15.35%188 399